{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-006036","form_type":"8-K","ticker":"ANEB","cik":"0001815974","company_name":"Anebulo Pharmaceuticals, Inc.","filed_at":"2025-02-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.019138+00:00","generated_at":"2026-05-26T22:58:40.097014+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Anebulo sets 2025 annual meeting for April 4; stockholder proposals due Feb 22","bullets":["Annual Meeting scheduled for April 4, 2025; location to be in proxy materials.","Stockholder proposals for inclusion in proxy must be received by February 22, 2025.","Director nominations and other proposals not in proxy also due by February 22, 2025.","Universal proxy rule compliance deadline is February 22, 2025 (10 days after 8-K filing).","Meeting date more than 30 days after prior year's anniversary, resetting prior deadlines."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-006036","json":"https://secwatch.observer/filing/0001493152-25-006036.json","markdown":"https://secwatch.observer/filing/0001493152-25-006036.md","text":"https://secwatch.observer/filing/0001493152-25-006036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815974/000149315225006036/0001493152-25-006036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815974/000149315225006036/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T22:58:40.097014+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}